Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Castelnau Le Lez, France Clinical Trials

A listing of Castelnau Le Lez, France clinical trials actively recruiting patients volunteers.

Found (132) clinical trials

Molecular Genetic Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma

This pro - and retrospective multicenter clinical epidemiological study studies the molecular genetic, host-derived and clinical determinants of glioblastoma patients with an overall survival of more than 5 years. The different research focusses are: Identification of clinical parameters and patient characteristics / host-related factors in long-term survivors (Focus 1) Identification …

Phase N/A

1.85 miles

Learn More »

Influence of Socio-Economic Factor on Net Survival in Patients With Multiple Sclerosis in France ( ECOVIMUS).

Background: In comparison to general population, persons with Multiple Sclerosis have a higher risk to premature death with an estimate reduced life expectancy from 7 to 14 years. However, risk factors of mortality in MS are not well identified and well known. Following the example of studies carry on cancers …

Phase N/A

1.85 miles

Learn More »

Dat'Aids Prevention

DatAIDS prevention is a cohort study of HIV prevention in over 23 HIV sites in France including overseas, aiming to describe HIV prevention in every aspect including HIV screening, STI and hepatitis screening, post-exposure prophylaxis and pre-exposure prophylaxis

Phase N/A

1.85 miles

Learn More »

OFSEP High Definition Cohort

For neurologists and patients, it appears that one major unmet need, beside of course a cure to multiple sclerosis (MS), is to better appreciate the causal factors of disease progression, and even to obtain reliable predictive tools that could apply on the individual level and at different key moments in …

Phase N/A

1.85 miles

Learn More »

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere in the Treatment of Hepatocellular Carcinoma (HCC)

TheraSphere is a radioembolic therapeutic device used in the treatment of liver cancers. The goal of the registry study is to collect prospectively: participant description, treatment goal, treatment description, treatment results, safety, quality of life and survival data to ultimately demonstrate that TheraSphere treatment meets the claims that led to …

Phase N/A

1.85 miles

Learn More »

Safety and Performance of the Neuroform Atlas Stent System

This proposed ATLAS FR study will be a retrospective review conducted to expand our knowledge of the clinical outcomes in subjects treated in France between 01 February 2017 and 01 March 2018. This will provide a comprehensive data set that is specifically representative of the Atlas stent use in France.

Phase N/A

1.85 miles

Learn More »

Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity

Chronic iron overload are responsible for morbidity and mortality. There are many causes, genetic and acquired. Hepcidin deficiency related to genetic desease is one of them. This study concerns specifically this cause, and seeks to characterize these iron overloads on clinical, biological, genetic and functional point of view. A significant …

Phase N/A

1.85 miles

Learn More »

A Study of Biomarkers of Mild Traumatic BRAIN Injury

Patients with mild traumatic brain injury (mTBI) represent a burden of patients admitted to the emergency department. According to the guidelines, a cerebral CT scan is indicated after mTBI according to the specific conditions. However, variability exists regarding the respect of these CT scan indications, and less than 10% of …

Phase N/A

1.85 miles

Learn More »

French COVID Cohort

Infectious disease is the single biggest cause of death worldwide. New infectious agents, such as the SARS, MERS and other novel coronavirus, novel influenza viruses, viruses causing viral haemorrhagic fever (e.g. Ebola), and viruses that affect the central nervous system (CNS) such as TBEV & Nipah require investigation to understand …

Phase N/A

1.85 miles

Learn More »

Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs

Retrospective and prospective multicentric observational registry in French intensive care units (ICU) including all consecutive adult patients admitted in ICU with a documented SARS-CoV-2 disease : For an out-of-hospital or an in-hospital cardiac arrest (OHCA and IHCA respectively) Or presenting an unexpected in-ICU cardiac arrest (ICUCA) Patients characteristics, cardiac arrest …

Phase N/A

1.85 miles

Learn More »